Treatment options for recurrent endometrial cancer are limited, Most patients with recurrent disease are treated with palliative chemotherapy or radiation therapy, and results are poor even when there is only a vaginal cuff recurrence, Traditionally, cytoreductive surgery does not have a definite role in the treatment of patients with recurrent endometrial cancer. It was unclear if maximal cytoreductive surgery could carry benefit in pelvic and abdominal recurrent endometrial carcinoma. In recent reports, cytoreductive surgery was found to have an efficacy in women with large pelvic or abdominal recurrence from endometrial cancer. Tumor can be completely resected in the majority of the patients. Complete salvage cytoreductive surgery for recurrent endometrial cancer is associated with prolonged post-recurrence survival. However, careful selection of patients is needed to minimize mobility and mortality.